U.S. Markets open in 5 hrs 16 mins

Aptose Biosciences Inc. (APTO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4000-0.0700 (-2.02%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.30
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 37.3000
52 Week Low 33.3300
50-Day Moving Average 34.9003
200-Day Moving Average 34.6765

Share Statistics

Avg Vol (3 month) 34.47M
Avg Vol (10 day) 34.31M
Shares Outstanding 588.94M
Implied Shares Outstanding 6N/A
Float 69.06M
% Held by Insiders 14.61%
% Held by Institutions 154.64%
Shares Short (Apr 14, 2021) 43.69M
Short Ratio (Apr 14, 2021) 40.37
Short % of Float (Apr 14, 2021) 44.17%
Short % of Shares Outstanding (Apr 14, 2021) 44.15%
Shares Short (prior month Mar 14, 2021) 42.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Oct 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.74%
Return on Equity (ttm)-51.91%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -55.62M
Net Income Avi to Common (ttm)-55.24M
Diluted EPS (ttm)-0.6750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)122.39M
Total Cash Per Share (mrq)1.38
Total Debt (mrq)1.07M
Total Debt/Equity (mrq)0.90
Current Ratio (mrq)18.36
Book Value Per Share (mrq)1.34

Cash Flow Statement

Operating Cash Flow (ttm)-33.89M
Levered Free Cash Flow (ttm)-13.14M